EuroIntervention PCRonline - Connecting with the community

Marco Valgimigli

41 articles

Prognostic Impact of Invasive Hemodynamic Measurements in Combination with Clinical and Echocardiographic Characteristics on 2-year Clinical Outcomes of Patients undergoing Transcatheter Aortic Valve Implantation

EuroIntervention 2017; just accepted article published in January 2017

Ischemic and Bleeding Outcomes in Elderly Patients Undergoing a Prolonged versus Shortened Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention. Insights from the PRODIGY randomized trial

EuroIntervention 2017; just accepted article published in January 2017

A double-blind randomised study to evaluate the efficacy and safety of bindarit in preventing coronary stent restenosis

EuroIntervention 2016;12:e1385-e1385

Published in Volume 12 Number 11, December 2016

Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial

EuroIntervention 2016;12:1239-1245 published online ahead of print November 2015

Published in Volume 12 Number 10, November 2016

A tool for predicting the outcome of reperfusion in ST-elevation myocardial infarction using age, thrombotic burden and index of microcirculatory resistance (ATI score)

EuroIntervention 2016;12:1223-1230

Published in Volume 12 Number 10, November 2016

Assessing the cardiology community position on transradial intervention and the use of bivalirudin in patients with acute coronary syndrome undergoing invasive management: results of an EAPCI survey

EuroIntervention 2016;12:1154-1163 published online ahead of print December 2015

Published in Volume 12 Number 9, October 2016

How should I treat this unusual anterolateral ST-elevation myocardial infarction with recurrent ventricular fibrillation and cardiac arrest?

EuroIntervention 2016;12:928-932

Published in Volume 12 Number 7, September 2016

Will LEADERS-FREE change my practice? A randomised double-blind comparison of the BioFreedom™ drug-coated stent vs. the Gazelle™ bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy

EuroIntervention 2016;12:798-800

Published in Volume 12 Number 6, August 2016

Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment

EuroIntervention 2016;12:e623-e631 published online e-edition August 2016

Published in Volume 12 Number 5, August 2016

Appraising the safety and efficacy profile of left atrial appendage closure in 2016 and the future clinical perspectives. Results of the EAPCI LAAC survey

EuroIntervention 2016;12:112-118

Published in Volume 12 Number 1, May 2016

Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study

EuroIntervention 2016;12:30-37

Published in Volume 12 Number 1, May 2016

Left main or proximal left anterior descending coronary artery disease location identifies high-risk patients deriving potentially greater benefit from prolonged dual antiplatelet therapy duration

EuroIntervention 2016;11:e1222-e1230 - published online ahead of print August 2015 - published online e-edition February 2016

Published in Volume 11 Number 11, February 2016

Antithrombotic therapy in TAVI patients: changing concepts

EuroIntervention 2015;11:W92-W95

Published in Volume 11 Supplement W, September 2015

Rapid exchange ultra-thin microcatheter using fibre-optic sensing technology for measurement of intracoronary fractional flow reserve

EuroIntervention 2015;11:428-432 published online ahead of print May 2015

Published in Volume 11 Number 4, August 2015

Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey

EuroIntervention 2015;11:68-74

Published in Volume 11 Number 1, May 2015

Optical coherence tomography appraisal of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing intraprocedural versus post-stenting prolonged bivalirudin infusion. Rationale and design of the MATRIX (Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and angioX) OCT substudy

EuroIntervention 2015;10:1311-1317 published online ahead of print February 2015

Published in Volume 10 Number 11, March 2015

Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force

EuroIntervention 2015;10:1095-1108 published online ahead of print August 2014

Published in Volume 10 Number 9, January 2015

2014 ESC/EACTS Guidelines on myocardial revascularization

EuroIntervention 2015;10:1024-1094  published online ahead of print September 2014

Published in Volume 10 Number 9, January 2015

Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement

EuroIntervention 2015;10:1015-1021

Published in Volume 10 Number 9, January 2015

The conundrum of antithrombotic drugs before, during and after primary PCI

EuroIntervention 2014;10-T64-T73

Published in Volume 10 Supplement T, August 2014

Quantification of scientific output in cardiovascular medicine: a perspective based on global data

EuroIntervention 2013;9:975-978 published online ahead of print August 2013

Published in Volume 9 Number 8, December 2013

Stent-related defects in patients presenting with stent thrombosis: differences at optical coherence tomography between subacute and late/very late thrombosis in the Mechanism Of Stent Thrombosis (MOST) study

EuroIntervention 2013;9:936-944

Published in Volume 9 Number 8, December 2013

Deferred angioplasty and stenting in primary percutaneous coronary intervention: one step back, two steps forward?

EuroIntervention 2013;8:1119-1123

Published in Volume 8 Number 10, February 2013

Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched study

EuroIntervention 2012;8:486-492 published online ahead of print June 2012

Published in Volume 8 Number 4, August 2012

Does the site of bleeding matter? A stratified analysis on location of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarction

EuroIntervention 2012;8:71-78 publish online ahead of print February 2012

Published in Volume 8 Number 1, May 2012

Rationale and design of the EXAMINATION trial: a randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarction

EuroIntervention 2011;7:977-984 publish online ahead of print November 2011

Published in Volume 7 Number 8, December 2011

Cardiovascular risk profile of patients included in stent trials; a pooled analysis of individual patient data from randomised clinical trials: insights from 33 prospective stent trials in Europe

EuroIntervention 2011;7:859-871

Published in Volume 7 Number 7, November 2011

Percutaneous coronary intervention versus bypass surgery for left main coronary artery disease: a meta-analysis of randomised trials

EuroIntervention 2011;7:738-746 publish online ahead of print August 2011

Published in Volume 7 Number 6, October 2011

AMI on the move

EuroIntervention 2011;7:415-419

Published in Volume 7 Number 4, August 2011

Looking back into the future: desirudin in acute coronary syndromes and coronary stenting

EuroIntervention 2011;7:263-269

Published in Volume 7 Number 2, June 2011

Real-time clopidogrel gain-of-function and loss-of function genotype screening with NanosphereVerigene2C19/CBSNucleic Acid

Published in Volume 7 Supplement M, May 2011

Tissue coverage and neointimal hyperplasia of overlap vs. non-overlap segments in DES 9-13 months after implantation: in vivo-assessment with optical coherence tomography

Published in Volume 7 Supplement M, May 2011

Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update

EuroIntervention 2010;6:39-45 - DOI10.4244/EIJV6I1A7

Published in Volume 6 Number 1, May 2010

Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-DELFT)

EuroInterv.2008;4:77-83

Published in Volume 4 Number 1, May 2008

Revisiting the incidence and temporal distribution of cardiac and sudden death in patients undergoing elective intervention for unprotected left main coronary artery stenosis in the drug eluting stent era
A pooled analysis on 340 patients treated at three European referral centres

EuroInterv.2007;2:435-443

Published in Volume 2 Number 4, February 2007

Use of Impella Recover® LP 2.5 left ventricular assist device during high-risk percutaneous coronary interventions; clinical, haemodynamic and biochemical findings

EuroIntervention 2006;2:91-100 - DOI10.4244/EIJV2I1A15

Published in Volume 2 Number 1, May 2006

Myocardial repair by percutaneous cell transplantation of autologous skeletal myoblast as a stand alone procedure in post myocardial infarction chronic heart failure patients

EuroInterv.2006;1:417-424

Published in Volume 1 Number 4, February 2006

Drug-eluting stent implantation for chronic total occlusions: comparison between the Sirolimus- and Paclitaxel-eluting stent

EuroInterv.2005;2:193-197

Published in Volume 1 Number 2, August 2005

EuroPCR highlights 2005

EuroInterv.2005;2:139-144

Published in Volume 1 Number 2, August 2005

Beyond crossing a chronic total occlusion. Are the drug-eluting stents the solution for this old problem?

EuroInterv.2005;2:129-131

Published in Volume 1 Number 2, August 2005

Treatment of de novo bifurcation lesions: comparison of Sirolimus- and Paclitaxel-eluting stents

EuroIntervention 2005;1:24-30 - DOI10.4244/EIJV1I1A01

Published in Volume 1 Number 1, May 2005